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T h e  r i s k  o f  i n t r a o p e r a t i v e  H u m a n  
Immunodeficiency Virus (HIV) infection  poses a 
challenge to practicing surgeons worldwide, 
particularly in sub-Saharan Africa with its high HIV 
prevalence. The risk of acquiring HIV infection from 
one infected percutaneous exposure is 0.3-0.4% . 
Prior to extensive screening, blood transfusions 
were responsible for an estimated 5-10% of new HIV 
infections in sub-Saharan Africa. In this paper we 
describe the experience of minimally invasive 
techniques as alternatives to surgery in urology 
patients. Trans-urethral ethanol ablation of the 
prostate (TEAP) for prostatic enlargement, phenol 
sclerotherapy for hydroceles, and percutaneous 
aspiration and sclerotherapy for symptomatic renal 
cysts may result in reduced blood loss, and 
diminished contact with the patients' exposed tissues 
or body fluids compared with more invasive surgical 
options.
INTRODUCTION
Human Immunodeficiency Virus and Acquired 
Immunodeficiency Syndrome (HIV/AIDS) are 
among the most difficult challenges facing 
practicing surgeons worldwide. Surgeons are at risk 
of occupationally-acquired infection as a result of 
intimate contact with the blood and other body fluids 
1
of HIV positive patients requiring surgery . The 
challenge is more acute in sub-Saharan Africa as it 
currently has the highest prevalence of HIV infection 
in the world. Zambia alone has an estimated 1.1 
million people infected with HIV. Other bloodborne 
infections, such as hepatitis B and C also pose 
significant risks, although the prevalence of 
infection in Zambia is not well known. This article 
will summarize the infectious transmission risks 
inherent to surgical procedures and the potential 
strategies for reducing those risks.  We will further 
describe three minimally invasive urologic 
procedures that can be considered as a part of this 
risk-reduction strategy. 
BACKGROUND 
Surgeons routinely work with potentially infectious 
materials. The risk of acquiring a disease from one 
percutaneous exposure is 0.3-0.4% for human 
immunodeficiency virus (HIV),  6-30% for 
hepatitis B virus (HBV) and 2.7-10% for hepatitis C 
virus (HCV). Rates of blood contacts vary but may 
2
reach up to 11.9 per 100 h in the operating room . 
The risk of occupational blood-borne infections for 
health care workers (HCWs) has been reassessed in 
the last decades in relation to the spread of 
pathogens associated with significant morbidity and 
mortality, in particular HBV, 1HCV and HIV.  At-risk 
incidents have been identified as needle stick 
injuries or cuts with contaminated instruments, as 
well as blood contamination of open wound or of 
mucous membranes and possibly of a wide skin area 
3,4
with prolonged contact . 
Blood transfusions are another significant mode of 
HIV transmission in the health care setting. Prior to 
the extensive screening of blood products, 
transfusions were responsible for an estimated 5-
2110% of new HIV infections in sub-Saharan Africa . 
More recently, The transfusion-associated risks of 
becoming infected with HIV, HBV, and HCV in sub-
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Saharan Africa were 1, 4.3, and 2.5 infections per 
1000 units, respectively. If annual transfusion 
requirements projected by the WHO were met, 
transfusions alone would be responsible for 28,595 
HBV infections, 16,625 HCV infections, and 6650 
HIV infections every year. Sensitivity analysis 
5
suggests that the true risks may be even higher . 
The risk of contracting HIV infection for a surgeon 
6practicing in Zambia for 5 years is 1.5% . The risk for 
a surgeon working in a Western hospital is estimated 
7at 0.1% . Although occupational exposure rate was 
relatively low, the HIV seroprevalence was so high 
that the relative accumulated seroconversion risk for 
surgeons in tropical Africa has been estimated to be 
15 times higher than in Western countries. This 
implies that each year one out of every 300 African 
surgeons may become occupationally infected with 
HIV, and the risk is likely similar among other 
6
healthcare workers frequently exposed to sharps . 
The risk of becoming infected with blood-borne 
pathogens during surgery is real. The degree of risk 
for peri-operative personnel is related to factors that 
include participating in large numbers of surgical 
procedures each year; the nature of peri-operative 
work (e.g., use of different types of sharp 
instruments); exposure to large amounts of blood 
and body fluids; the prevalence of blood-borne 
pathogens in the surgical population. Controlling 
risks to peri-operative personnel can be 
accomplished by using the Occupational Safety and 
Health Administration's three methods of control-
redesigning surgical equipment and procedures, 
changing work practices, and enhancing the 
personal protection equipment of peri-operative 
8
personnel . 
PATHOGEN EXPOSURE RISK DURING 
PROCEDURE
Researchers reviewing operating room (OR) studies 
in detail have found a percutaneous injury rate of 
between 1.7% and 15% during periods ranging from 
1 to 10 months, depending on the type of operation 
and other factors The occupational groups 
participating in surgery who sustain the greatest 
number of percutaneous and other injuries are 
surgical residents and surgeons. In one study, 
however, scrub people sustained as many 
9
percutaneous injuries as surgeons . 
STRATEGIES TO REDUCE RISK DURING 
SURGERY
It has been argued that using standard precautions is 
an insufficient strategy to reduce exposure to blood-
borne pathogens in the OR and that an industrial 
hygiene model would be more useful. This 
approach, in fact, is the basis for the Occupational 
Safety and Health Administration's (OSHA) blood 
10
borne pathogen standard . 
This model emphasizes a hierarchy of controls that 
should be applied in ORs in three levels: 
Level one - The first level of control involves 
modifying the tools with which work is performed 
rather than attempting to change human behaviour. 
In an OR, this could mean performing bloodless 
surgery (e.g., using ultrasound to reduce kidney 
stones rather than a laparotomy), as well as 
redesigning devices and equipment (e.g., use of 
blunt suture needles whenever possible). It also is 
possible to blunt other devices, such as scissors, 
retractors, and clamps. Although not available in our 
setting, the use of robots also can be considered a 
first level of control when robotic hands replace the 
surgeon's hands. When the data analysis controlled 
for potentially confounding factors (e.g., length of 
surgery, blood loss, type of procedure, surgical 
technique), researchers found that use of blunt 
needles was progressively more protective as more 
blunt needles replaced sharp ones. It also is possible 
to blunt other devices, such as scissors, retractors, 
11
and clamps .  
Level two - The second level in OSHA's hierarchy is 
work practice controls (i.e., changing the way in 
which the work is performed). Some of the safety 
recommendations made by individuals and 
professional associations at this level include 
substituting staples for sutures, announcing that a 
sharp will be passed, never tying sutures with the 
needle in your hand, and using the electrosurgical 
12
unit for cutting tissue . 
Level three - The third level of control promotes the 
use of personal protective equipment and other 
forms of personal protection. In the OR, gloves, 
gowns, masks, and protective eye wear, as well as 
the hepatitis B vaccine and post-exposure 
prophylaxis to HBV or HIV, are examples of this 
13
mitigating, third level of control . 
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In level one, measures involving the use of minimal 
invasive surgery aim to reduce the risk of exposure 
to infectious materials during surgery for the health 
workers and for the patients. Here we present three 
previously published case series that demonstrate 
our experience with minimally invasive urologic 
techniques that result in reduced blood loss and 
diminished contact with the patients' exposed 
tissues or body fluids. These effective techniques 
may be used in lieu of open surgery in appropriately 
selected patients. 
1. T R A N S U R E T H R A L  E T H A N O L  
ABLATION OF THE PROSTATE (TEAP) 
AS A TREATMENT OPTION FOR 
PROSTATIC OBSTRUCTION
Prostate disease accounts for 33% of urology 
conditions in Zambia. The most common of these is 
benign enlargement of the prostate (BEP). The 
standard care of patients with BEP in Zambia is 
either open prostatectomy or trans-urethral 
resection of the prostate (TURP). In open 
prostatectomy, blood transfusion is required in 
12.7% of the patients either intra-operatively or 
14
postoperatively .  In TURP, excessive bleeding is 
seen in around 3% of patients, and a patient may 
need a blood transfusion or a second operation to 
15stop the bleeding . Another complication, TURP 
syndrome, can  occur when a patient develops 
symptomatic hyponatremia secondary to the 
absorption of irrigating fluid through prostatic veins 
or breaches in the prostatic capsule during the 
procedure. 
We performed a prospective study at the University 
Teaching Hospital (UTH) in Lusaka, where we 
evaluated the effectiveness of  transurethral ethanol 
ablation fo the prostate (TEAP) as a treatment 
modality for obstructive BEP. This procedure 
involves the intra-prostatic injection of dehydrated 
alcohol and can be performed as a day case under 
regional anesthesia using cystoscopy.  The 
procedure is relatively simple and can be completed 
in about 15 minutes. 
A total of 45 patients with documented bladder 
outlet obstruction secondary to BEP were enrolled 
in the study. The patients were followed up for 30 
months post-operatively. The main results of the 
study are summarized in Figure 1. We found that 
intraprostatic ethanol injections  produced 
remarkable sustained symptomatic relief without 
any significant complications.   No patients required 
blood transfusion. One patient needed further 
intervention, and he underwent TURP 6 months 
later. The chief limitation of that study was the 
absence of a control group for comparison.
The benefits of the TEAP technique are mainly 
avoiding blood eye splash to the health workers in 
theatre, especially the surgeons, and avoiding blood 
16transfusion to the patients .
Figure 1: AUA symptom score before and after 
TEAP
2. SCLEROTHERAPY WITH PHENOL 
INSTEAD OF  OPERATIVE TREATMENT 
FOR HYDROCELE
The standard care of hydrocele in Zambia is 
hydroceletomy. Risks related to hydrocele surgery 
may include: blood clots, infection, and injury to the 
17scrotal tissue or structures .
A comparative study of sclerotherapy with phenol 
versus surgical treatment for hydrocele was 
conducted at UTH. A total of 80 patients with 
hydrocele were randomly divided into 2 groups of 
40 each. Group A underwent phenol sclerotherapy 
in the outpatient urology clinic and Group B 
underwent hydrocelectomy in theatre under 
anesthesia. In the sclerotherapy group 47.5%, 
32.5%, and 15% of the hydroceles were cured with 1 
to 3 injections, respectively (Figure 2), but 4% were 
not cured. There were no complaints of localized 
pain or infection in these cases. All patients returned 
to normal activities on the same day. In the 
hydrocelectomy group, all the patients were cured. 
There was pain postoperatively in 73.5% of the 
patients and localized infection in 9%, while 65% 
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required an average of 4 days of rest and were absent 
from work for 10 days. As with many surgical 
studies, one limitation of this study was that we were 
not able to blind patients and treating doctors to the 
group assignment. We concluded that sclerotherapy 
using phenol as treatment for hydrocele is as 
efficient as hydrocelectomy for cure, has lower risk 
of complications and allows the patients to return to 
normal activity on the same day.  Importantly, this 
technique resulted in diminished contact with the 
patients' exposed tissues or body fluids compared 
wi th  hydrocelec tomy.  Sc lero therapy i s  
recommended as an option for treatment of 
18
hydrocele .
Figure 2. Cure Rate and Number Of Applications
3. PERCUTANEOUS ASPIRATION AND 
ETHANOL SCLEROTHERAPY FOR 
TREATMENT OF SYMPTOMATIC 
SIMPLE RENAL CYSTS
The standard care of symptomatic simple renal cyst 
in Zambia is open decortications of the  cyst. Open 
surgical cyst decortication for pain relief through an 
abdominal incision is  associated with considerable 
morbidity and protracted convalescence and must be 
19
done under general anaesthesia .
We enrolled 17 patients (11 men and 6 women, mean 
age of 46 years) with symptomatic simple renal 
cysts seen at the UTH urology clinic. The patients 
were treated by ultrasonography (US)-guided 
percutaneous aspiration and with an injection of 
95% ethanol. Patients were evaluated 1 month 
postoperatively and every 6 months thereafter by 
clinical assessment, US, and intravenous urography. 
Success was defined as complete when there was 
total ablation of the cyst and partial when there was a 
recurrence of less than half the original cyst volume 
and a resolution of symptoms. Failure was defined 
as the recurrence of more than half of cyst volume or 
persistent symptoms.
During a mean follow-up of 19 months (range 
14–40), there was complete cyst ablation in 15 
(88%) patients and partial resolution in 2 (12%). No 
treatment failures occurred. The study was limited 
by the lack of a control group.
Ethanol sclerotherapy for symptomatic simple renal 
cysts is simple, minimally invasive, and highly 
effective. We recommend it as the first therapeutic 
option in these patients. This technique resulted in 
reduced blood loss, and diminished contact with the 
20
patients' exposed tissues or body fluids . 
CONCLUSION
A tremendous amount of work is necessary to 
redesign surgical sharps and procedures so that 
exposure to blood and body fluid is reduced 
significantly during operation.  Such work is 
necessary to improve the safety for healthcare 
workers, and OSHA's three levels of control provide 
good methodology to reduce the risk of blood borne 
pathogen transmission during operations. 
But arguably, the best way to reduce blood-borne 
infection risk is to preferentially select effective 
procedures that limit surgeons' exposure to body 
fluids and limit patients' blood loss and transfusion 
requirements. We feel that the three procedures 
described here accomplish these goals and should be 
considered as good therapeutic options, particularly 
in regions with high HIV and hepatitis prevalence.
Table 1: The demographic characteristics, clinical 














1st injection 2nd injection 3rd injection
cure rate
Characteristics No. of patients 
Sex  
  Male 11 (65%) 
  Female   6 (35%) 
Laterality  
  Right   9 (53%) 
  Left   8 (47%) 
Success  
  Complete 15 (88%) 
  Partial   2 (12%) 
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